JP2023521116A5 - - Google Patents

Info

Publication number
JP2023521116A5
JP2023521116A5 JP2022561396A JP2022561396A JP2023521116A5 JP 2023521116 A5 JP2023521116 A5 JP 2023521116A5 JP 2022561396 A JP2022561396 A JP 2022561396A JP 2022561396 A JP2022561396 A JP 2022561396A JP 2023521116 A5 JP2023521116 A5 JP 2023521116A5
Authority
JP
Japan
Prior art keywords
alkylene
alkyl
compound
salt
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022561396A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521116A (ja
JP7721561B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/022656 external-priority patent/WO2021206876A1/en
Publication of JP2023521116A publication Critical patent/JP2023521116A/ja
Publication of JP2023521116A5 publication Critical patent/JP2023521116A5/ja
Application granted granted Critical
Publication of JP7721561B2 publication Critical patent/JP7721561B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022561396A 2020-04-10 2021-03-17 ノロウイルス及びコロナウイルス複製の阻害剤 Active JP7721561B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063008183P 2020-04-10 2020-04-10
US63/008,183 2020-04-10
US202063027495P 2020-05-20 2020-05-20
US63/027,495 2020-05-20
PCT/US2021/022656 WO2021206876A1 (en) 2020-04-10 2021-03-17 Inhibitors of norovirus and coronavirus replication

Publications (3)

Publication Number Publication Date
JP2023521116A JP2023521116A (ja) 2023-05-23
JP2023521116A5 true JP2023521116A5 (cg-RX-API-DMAC10.html) 2024-03-26
JP7721561B2 JP7721561B2 (ja) 2025-08-12

Family

ID=75439538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022561396A Active JP7721561B2 (ja) 2020-04-10 2021-03-17 ノロウイルス及びコロナウイルス複製の阻害剤

Country Status (13)

Country Link
US (1) US20230159453A1 (cg-RX-API-DMAC10.html)
EP (1) EP4132944A1 (cg-RX-API-DMAC10.html)
JP (1) JP7721561B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230008079A (cg-RX-API-DMAC10.html)
CN (1) CN115698035A (cg-RX-API-DMAC10.html)
AU (1) AU2021254045A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022019557A2 (cg-RX-API-DMAC10.html)
CA (1) CA3179697A1 (cg-RX-API-DMAC10.html)
IL (1) IL297069A (cg-RX-API-DMAC10.html)
MX (1) MX2022012714A (cg-RX-API-DMAC10.html)
PH (1) PH12022552486A1 (cg-RX-API-DMAC10.html)
TW (1) TW202204318A (cg-RX-API-DMAC10.html)
WO (1) WO2021206876A1 (cg-RX-API-DMAC10.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021202460A1 (en) 2020-03-30 2021-10-07 Kansas State University Research Foundation Broad spectrum antivirals against coronavirus
US11124497B1 (en) 2020-04-17 2021-09-21 Pardes Biosciences, Inc. Inhibitors of cysteine proteases and methods of use thereof
US11174231B1 (en) 2020-06-09 2021-11-16 Pardes Biosciences, Inc. Inhibitors of cysteine proteases and methods of use thereof
EP4635972A3 (en) 2020-07-20 2025-12-24 Enanta Pharmaceuticals, Inc. Functionalized peptides as antiviral agents
US11351149B2 (en) * 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
WO2022109360A1 (en) 2020-11-23 2022-05-27 Enanta Pharmaceuticals, Inc. Novel spiropyrrolidine derived antiviral agents
US12540141B2 (en) 2020-11-23 2026-02-03 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
US11384090B2 (en) 2020-11-23 2022-07-12 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
US11352363B1 (en) 2020-11-23 2022-06-07 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
CN116685573B (zh) * 2021-01-19 2025-12-12 中国人民解放军军事科学院军事医学研究院 含有n-(取代磺酰基)乙酰胺结构的病毒蛋白酶抑制剂,及其在抗病毒药物中的应用
US20240307419A1 (en) * 2021-01-29 2024-09-19 Kansas State University Research Foundation Conformationally-constrained inhibitors of 3c or 3c-like proteases
US11970502B2 (en) 2021-05-04 2024-04-30 Enanta Pharmaceuticals, Inc. Macrocyclic antiviral agents
US12398147B2 (en) 2021-05-11 2025-08-26 Enanta Pharmaceuticals, Inc. Macrocyclic spiropyrrolidine derived antiviral agents
US11319325B1 (en) 2021-05-11 2022-05-03 Enanta Pharmaceuticals, Inc. Macrocyclic spiropyrrolidine derived antiviral agents
JP2024522990A (ja) * 2021-06-02 2024-06-25 エイシア セラピューティクス, インコーポレイテッド 抗ウイルス薬としてのプロテアーゼ阻害剤
WO2022266363A1 (en) * 2021-06-16 2022-12-22 The Scripps Research Institute Protease inhibitors for the treatment of coronavirus infections
US11325916B1 (en) 2021-07-29 2022-05-10 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
US12643905B2 (en) 2021-07-23 2026-06-02 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
US11339170B1 (en) 2021-07-23 2022-05-24 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
US12479854B2 (en) 2021-07-29 2025-11-25 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
JP2024530920A (ja) * 2021-08-03 2024-08-27 コクリスタル ファーマ,インコーポレイテッド コロナウイルスに対する阻害剤
US11858945B2 (en) 2021-11-12 2024-01-02 Enanta Pharmaceuticals, Inc. Alkyne-containing antiviral agents
WO2023086400A1 (en) 2021-11-12 2023-05-19 Enanta Pharmaceuticals, Inc. Novel spiropyrrolidine derived antiviral agents
WO2023086352A1 (en) 2021-11-12 2023-05-19 Enanta Pharmaceuticals, Inc. Novel spiropyrrolidine derived antiviral agents
US11993600B2 (en) 2021-12-08 2024-05-28 Enanta Pharmaceuticals, Inc. Saturated spirocyclics as antiviral agents
WO2023107417A1 (en) 2021-12-08 2023-06-15 Enanta Pharmaceuticals, Inc. Heterocyclic antiviral agents
WO2023133174A1 (en) * 2022-01-07 2023-07-13 Merck Sharp & Dohme Llc Protease inhibitors for treating or preventing coronavirus infection
US20250064789A1 (en) * 2022-03-01 2025-02-27 Westvac Biopharma Co., Ltd. Ketoamide derivatives and pharmaceutical uses thereof
US12145942B2 (en) 2022-04-05 2024-11-19 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
CN115260074B (zh) * 2022-08-02 2024-06-21 爱斯特(成都)生物制药股份有限公司 一种口服抗病毒药物Paxlovid中间体的制备方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4131648A (en) 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4079038A (en) 1976-03-05 1978-03-14 Alza Corporation Poly(carbonates)
CY1308A (en) 1979-12-06 1985-12-06 Glaxo Group Ltd Device for dispensing medicaments
US4304767A (en) 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4353656A (en) 1980-10-14 1982-10-12 Xerox Corporation Moving coil, multiple energy print hammer system including a closed loop servo
EP0069715B1 (en) 1981-07-08 1986-11-05 Aktiebolaget Draco Powder inhalator
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
DK172541B1 (da) 1982-10-08 1998-12-07 Glaxo Group Ltd Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
US4501729A (en) 1982-12-13 1985-02-26 Research Corporation Aerosolized amiloride treatment of retained pulmonary secretions
US4753788A (en) 1985-01-31 1988-06-28 Vestar Research Inc. Method for preparing small vesicles using microemulsification
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
US4946931A (en) 1989-06-14 1990-08-07 Pharmaceutical Delivery Systems, Inc. Polymers containing carboxy-ortho ester and ortho ester linkages
AU6909091A (en) 1989-12-05 1991-06-26 Ramsey Foundation Neurologic agents for nasal administration to the brain
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US5968543A (en) 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
CA2379909C (en) 1999-08-06 2011-01-04 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US7252840B1 (en) 1999-08-25 2007-08-07 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles
US6632666B2 (en) 2000-01-14 2003-10-14 Biolife Solutions, Inc. Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
WO2002013897A2 (en) 2000-08-14 2002-02-21 Advanced Inhalation Research, Inc. Inhalation device and method
CA2433335C (en) 2000-12-29 2010-04-20 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US6848197B2 (en) 2001-04-18 2005-02-01 Advanced Inhalation Research, Inc. Control of process humidity to produce large, porous particles
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
CA2465675C (en) 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
US7008644B2 (en) 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
WO2005023335A2 (en) 2003-09-05 2005-03-17 Kurve Technology, Inc. Integrated nebulizer and particle dispersing chamber for delivery of medicament
US7462594B2 (en) * 2003-12-31 2008-12-09 Taigen Biotechnology Co., Ltd. Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases
JP2007536240A (ja) * 2004-05-04 2007-12-13 アカデミア シニカ 抗コロナウイルス化合物
WO2005113580A1 (en) * 2004-05-21 2005-12-01 Pfizer Inc. Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
WO2006061714A2 (en) * 2004-12-09 2006-06-15 Pfizer Inc. Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
AU2011343647A1 (en) * 2010-12-16 2013-05-02 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
CA2850003C (en) 2011-09-27 2020-01-07 Kansas State University Research Foundation Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
CN103145608B (zh) 2011-12-07 2015-09-02 南开大学 抗肠病毒71(ev71)己内酰胺类化合物及其制备方法和用途
CN106928206B (zh) 2015-12-31 2022-02-18 中国科学院上海药物研究所 醛基类化合物及其制法和用途
US11013779B2 (en) 2016-06-20 2021-05-25 Kansas State University Research Foundation Small molecule therapeutic inhibitors against picornaviruses, caliciviruses, and coronaviruses
CN110818691A (zh) 2018-08-09 2020-02-21 中国科学院上海药物研究所 酮酰胺类化合物及其制备方法、药物组合物和用途
CN110105348A (zh) 2019-03-08 2019-08-09 南开大学 新型迈克尔受体类肠病毒71型抑制剂的制备及用途

Similar Documents

Publication Publication Date Title
RU2003110577A (ru) Гетероциклические соединения, связывающиеся с хемокиновыми рецепторами
RU2419626C2 (ru) Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы
SI2961736T1 (en) Histone demethylase inhibitors
JP2022504949A5 (cg-RX-API-DMAC10.html)
AR056217A1 (es) Compuestos heterociclicos utiles para el tratamiento de la enfermedad de alzheimer, neurodegeneracion y demencia
AR053652A1 (es) Derivados de indol como inhibidores de proteina quinasas. composiciones farmaceuticas
RU2330019C2 (ru) Производные пиперидина, способ их получения, фармацевтическая композиция на их основе и способ лечения хемокин-опосредованного болезненного состояния с их использованием
AR039659A1 (es) Inhibidores de metaloproteinasa de heteroariloxi-aril-espiro-pirimidina-2,4,6-triona n-sustituida metaloproteinasa
AR050619A1 (es) Derivados de adamantilo
AR044614A1 (es) Composiciones de sulfonamida que modulan la actividad del receptor de quinioquinas (ccr4)
AR060658A1 (es) Derivados de diceto-piperazina y piperidina como agentes antivirales
RU2009148673A (ru) Производные пиразинона и их применение для лечения легочных заболеваний
AR041672A1 (es) Compuesto biciclico de benzamida, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento y procedimiento para prepararlo
RU2012108173A (ru) Терапевтические арил-амидо-арильные соединения и их применение
AR051294A1 (es) Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
JP2009535356A5 (cg-RX-API-DMAC10.html)
AR033379A1 (es) Compuestos de difenilurea, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
JP2008504274A5 (cg-RX-API-DMAC10.html)
JP2005511746A5 (cg-RX-API-DMAC10.html)
AR036046A1 (es) Inhibidores de la hiv proteasa, composiciones que las contienen y sus usos farmaceuticos
AR051156A1 (es) Compuestos a base de bicicloheteroarilaminas como ligandos de los canales ionicos,usos de los mismos y composiciones farmaceuticas que los contienen
JP2024538694A5 (cg-RX-API-DMAC10.html)
JP2023504542A5 (cg-RX-API-DMAC10.html)
JP2023522990A5 (cg-RX-API-DMAC10.html)
JP2007521325A5 (cg-RX-API-DMAC10.html)